Quintiles and the Muscular Dystrophy Association (MDA) have partnered to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will help determine effective treatments for muscular dystrophy and related muscle diseases. MDA will use the registry to study the natural history of muscular dystrophy and related muscle diseases, collect information on practice patterns and inform care guidelines.    “We are making remarkable progress in researching new lifesaving trea...